Guardant Health, Inc.· GH
🇺🇸 US · LargeBroad USNASDAQ
- Price
- $159.79
- Day
- +0.60%
- Mkt Cap
- $21.44B
- 52W Range
- $43.66 – $176.58
- Volume
- 1.52M
- Beta
- 1.59
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Three of these watchlist stocks have already passed their earnings tests.
Read full article
AngloGold Ashanti plc (âAngloGold Ashantiâ, âAGAâ, the âCompanyâ or the âGroupâ) said Q2 2026 free cash flow* rose 36% year-on-year to $727m, fu
Read full article
Guardant Health, Inc. (GH) Q2 2026 Earnings Call Transcript
Read full article
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today reported financial results for the quarter ended June 30, 2026. Second Quarter 2026 Financial Highlights For the three-month period ended June 30, 2026, as compared to the same period of 2025: Reported total revenue of $335.0 million, an increase of 44%, driven by: Oncology revenue of $219.1 million, an increase of 38%, and approximately 104,000 oncology tests, an increase of 63%.
Read full article
Although the revenue and EPS for Guardant Health (GH) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read full article
Guardant Health (GH) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.4. This compares to a loss of $0.44 per share a year ago.
Read full article
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the following investor conferences. Canaccord Genuity 46th Annual Growth Conference in Boston, MA Fireside chat on Wednesday, August 12th at 3:00 p.m. Eastern Time Morgan Stanley 24th Annual Global Healthcare Conference in New York, NY Fireside chat on Tuesday, September 15th at 7:45 a.m. Eastern Time Interested parties may access liv.
Read full article
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Guardant Health (GH), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2026.
Read full article
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the launch of a new video featuring actor and cancer advocate Patrick Dempsey that highlights the more than 55,000 Americans who will lose their lives to colorectal cancer (CRC) this year1, a majority of which will not have been up to date with their colorectal cancer screening.2 The video pays an emotional tribute to Americans from across the country who have passed fro.
Read full article
Caxton Associates LLP purchased a new position in shares of Guardant Health, Inc. (NASDAQ: GH) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 8,999 shares of the company's stock, valued at approximately $831,000. A number of other large investors also
Read full article
VOOG focuses on mega-cap tech leaders while ISCG diversifies across smaller firms.
Read full article
Guardant Health (GH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read full article